SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xiangjiao Meng, Zhaoqin Huang, Renben Wang, Jinming Yu, Prediction of response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer, BioScience Trends, 2014, 8, 1, 11

    CrossRef

  2. 2
    Robert Farkas, Eva Pozsgai, Andrew V. Schally, Andras Szigeti, Edit Szigeti, Zoltan Laszlo, Andras Papp, Eva Gomori, Laszlo Mangel, Peter O. Horvath, Szabolcs Bellyei, Possible predictors of histopathological response to neoadjuvant chemoradiotherapy for rectal cancer, Journal of Cancer Research and Clinical Oncology, 2012, 138, 3, 387

    CrossRef

  3. 3
    Alice Dewdney, David Cunningham, Toward the Non-surgical Management of Locally Advanced Rectal Cancer, Current Oncology Reports, 2012, 14, 3, 267

    CrossRef

  4. 4
    J.-P. Gérard, J. Baulieux, J. Doyen, J. Gal, E. Letouze, S. Olschwang, O. Chapet, P. Romestaing, Towards a “Lyon molecular signature” to individualize the treatment of rectal cancer. Prognostic analysis of a prospective cohort of 94 rectal cancers T1-2-3 Nx MO to be the basis of a molecular signature, Cancer/Radiothérapie, 2012, 16, 8, 688

    CrossRef

  5. 5
    Driffa Moussata, Souheila Amara, Bénazir Siddeek, Myriam Decaussin, Stephanie Hehlgans, Rachel Paul-Bellon, Françoise Mornex, Jean-Pierre Gerard, Pascale Romestaing, Franz Rödel, Bernard Flourie, Mohamed Benahmed, Claire Mauduit, XIAP as a Radioresistance Factor and Prognostic Marker for Radiotherapy in Human Rectal Adenocarcinoma, The American Journal of Pathology, 2012, 181, 4, 1271

    CrossRef

  6. 6
    Julio Garcia-Aguilar, Zhenbin Chen, David D. Smith, Wenyan Li, Robert D. Madoff, Peter Cataldo, Jorge Marcet, Carlos Pastor, Identification of a Biomarker Profile Associated With Resistance to Neoadjuvant Chemoradiation Therapy in Rectal Cancer, Annals of Surgery, 2011, 254, 3, 486

    CrossRef

  7. 7
    Nara Rosana Andrade, Celina Tizuko Fujiyama Oshima, Thiago Simão Gomes, Ricardo Artigiani Neto, Nora Manoukian Forones, Imunoexpression of Ki-67 and p53 in Rectal Cancer Tissue After Treatment with Neoadjuvant Chemoradiation, Journal of Gastrointestinal Cancer, 2011, 42, 1, 34

    CrossRef

  8. 8
    Zhenbin Chen, Marjun P. Duldulao, Wenyan Li, Wendy Lee, Joseph Kim, Julio Garcia-Aguilar, Molecular Diagnosis of Response to Neoadjuvant Chemoradiation Therapy in Patients with Locally Advanced Rectal Cancer, Journal of the American College of Surgeons, 2011, 212, 6, 1008

    CrossRef

  9. 9
    Martin Kruschewski, Kathrin Mueller, Sybille Lipka, Jan Budczies, Aurelia Noske, Heinz Johannes Buhr, Sefer Elezkurtaj, The Prognostic Impact of p53 Expression on Sporadic Colorectal Cancer Is Dependent on p21 Status, Cancers, 2011, 3, 4, 1274

    CrossRef

  10. 10
    S. Gollins, Radiation, chemotherapy and biological therapy in the curative treatment of locally advanced rectal cancer, Colorectal Disease, 2010, 12,
  11. 11
    F. M. Smith, D. Waldron, D. C. Winter, Rectum-conserving surgery in the era of chemoradiotherapy, British Journal of Surgery, 2010, 97, 12
  12. 12
    Akira Ichikawa, Kenjiro Kotake, Takashi Matsui, Yasuo Koyama, Koichi Suda, Takashi Yao, Classification of colorectal carcinoma obtained from the combination of DNA ploidy and genetic alterations serves as a significant prognostic factor, Journal of Gastroenterology, 2009,

    CrossRef

  13. 13
    Matthew F. Kalady, Luiz Felipe de Campos-Lobato, Luca Stocchi, Daniel P. Geisler, David Dietz, Ian C. Lavery, Victor W. Fazio, Predictive Factors of Pathologic Complete Response After Neoadjuvant Chemoradiation for Rectal Cancer, Transactions of the ... Meeting of the American Surgical Association, 2009, 127, 213

    CrossRef

  14. 14
    K. Shiomitsu, E. Sajo, X. Xia, D. W. Hunley, G. E. Mauldin, S. Li, G. N. Mauldin, Radiosensitivity of canine osteosarcoma cells transfected with wild-type p53 in vitro, Veterinary and Comparative Oncology, 2008, 6, 3
  15. 15
    Brian DP O'Neill, Gina Brown, RJ Heald, David Cunningham, Diana M Tait, Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer, The Lancet Oncology, 2007, 8, 7, 625

    CrossRef

  16. 16
    Cem Terzi, Aras Emre Canda, Ozgul Sagol, Koray Atila, Devrim Sonmez, Mehmet Fuzun, Ilknur B. Gorken, Ilhan Oztop, Funda Obuz, Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy, International Journal of Colorectal Disease, 2007, 23, 1, 37

    CrossRef

  17. 17
    Fraser M. Smith, John V. Reynolds, Elaine W. Kay, Paul Crotty, James O. Murphy, Donal Hollywood, Eoin F. Gaffney, Richard B. Stephens, M. John Kennedy, COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy, International Journal of Radiation Oncology*Biology*Physics, 2006, 64, 2, 466

    CrossRef

  18. 18
    F.M. Smith, J.V. Reynolds, N. Miller, R.B. Stephens, M.J. Kennedy, Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy, European Journal of Surgical Oncology (EJSO), 2006, 32, 1, 55

    CrossRef

  19. 19
    Anna A. Neschastnova, Victoria K. Gasanova, Vladimir I. Popenko, Andreana Lambrinakos, Gennady A. Belitsky, Richard G.H. Cotton, Marianna G. Yakubovskaya, Spontaneous DNA-DNA interaction of homologous duplexes and factors affecting the result of heteroduplex formation, Biological Chemistry, 2006, 387, 3

    CrossRef

  20. 20
    Jose M. Fernández-Cebrián, Peter Vorwald Kuborn, Mar Pardo de Lama, Alfonso Sanjuanbenito Dehesa, Manuel Nevado Santos, Pedro A. Pacheco Martínez, Beatriz Fernández-Escudero, Estado actual del valor pronóstico de los marcadores moleculares en pacientes con cáncer colorrectal y la predicción de respuesta al tratamiento adyuvante, Clinical and Translational Oncology, 2005, 7, 3, 101

    CrossRef

  21. 21
    Young Min Chung, Byoung-Gie Kim, Chang-Soo Park, Seung Jae Huh, Jhingook Kim, Jong Kuk Park, Sun Mi Cho, Byung Soo Kim, Jun Suk Kim, Young Do Yoo, Duk-Soo Bae, Increased expression of ICAM-3 is associated with radiation resistance in cervical cancer, International Journal of Cancer, 2005, 117, 2
  22. 22
    F M Smith, R B Stephens, M J Kennedy, J V Reynolds, P53 abnormalities and outcomes in colorectal cancer: a systematic review, British Journal of Cancer, 2005, 92, 9, 1813

    CrossRef

  23. 23
    E Lopez-Crapez, F Bibeau, S Thézenas, M Ychou, J Simony-Lafontaine, A Thirion, D Azria, J Grenier, P Senesse, p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis, British Journal of Cancer, 2005, 92, 12, 2114

    CrossRef

  24. 24
    Rosalyn D. Blumenthal, Evelyn Leone, David M. Goldenberg, Marisol Rodriguez, David Modrak, An in vitro model to optimize dose scheduling of multimodal radioimmunotherapy and chemotherapy: Effects of p53 expression, International Journal of Cancer, 2004, 108, 2
  25. 25
    Morton S. Kahlenberg, John M. Sullivan, Diana Dickson Witmer, Nicholas J. Petrelli, Molecular prognostics in colorectal cancer, Surgical Oncology, 2003, 12, 3, 173

    CrossRef

  26. 26
    Mef Nilbert, Eva Fernebro, Molecular Pathology, Colorectal Carcinoma, and Prostate Carcinoma, 2002,

    CrossRef